Blinkaid develops a medical device aimed at treating Dry Eye Syndrome (DES), a condition affecting hundreds of millions worldwide. Their technology delivers targeted therapy to restore tear film stability and alleviate discomfort, offering a non‑pharmaceutical solution for patients who struggle with chronic dry eye. By integrating portable, user‑friendly hardware, Blinkaid enables regular at‑home treatment, improving quality of life and reducing reliance on eye drops.
Funding
Funding not disclosed
Founders
Product
Problem
Dry Eye Syndrome (DES) affects hundreds of millions of people worldwide, causing discomfort, visual disturbances, and reduced quality of life. Current treatments rely heavily on artificial tears and prescription medications, which provide only temporary relief and may have side effects.
Solution
Blinkaid has developed a medical device that delivers a controlled, non‑pharmaceutical therapy to restore the natural tear film and improve ocular surface health. The device uses a proprietary micro‑fluidic or stimulation technology to promote tear production and stabilize the tear layer without the need for drops or drugs. By addressing the underlying deficiency in tear film, the solution aims to reduce symptoms such as dryness, irritation, and blurred vision, while enhancing visual comfort for users in daily activities.
Target Audience
Primary customers are individuals diagnosed with Dry Eye Syndrome, including adults and seniors, as well as eye care professionals seeking a non‑pharmaceutical treatment option for their patients.
Features
- Portable, battery‑operated device designed for home or office use
- Automated dosing regimen that delivers precise therapeutic pulses or micro‑droplets to the ocular surface
- Sensor‑based feedback to ensure correct positioning and safe operation
- Clinically validated protocol that targets tear film stability and ocular surface hydration
- Reusable components with replaceable consumables to minimize waste and cost
- User-friendly interface with simple one‑button activation and mobile app guidance